Quest Diagnostics Incorporated
General ticker "DGX" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $19.2B (TTM average)
Quest Diagnostics Incorporated follows the US Stock Market performance with the rate: 39.0%.
Estimated limits based on current volatility of 2.0%: low 183.24$, high 190.61$
Factors to consider:
- Earnings expected soon, date: 2026-01-29 bmo
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-10-03, amount 0.80$ (Y1.69%)
- Total employees count: 56000 as of 2024
- Top business risk factors: Regulatory and compliance, Strategic risks and growth management, Operational and conduct risks, Cybersecurity threats, Reputation and brand risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [141.30$, 194.01$]
- 2025-12-31 to 2026-12-31 estimated range: [149.01$, 205.57$]
Financial Metrics affecting the DGX estimates:
- Negative: with PPE of 17.1 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 13.64
- Positive: 6.63 < Operating cash flow per share per price, % of 7.90
- Negative: negative Industry operating cash flow (median)
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 5.29
- Positive: Industry inventory ratio change (median), % of -0.84 <= -0.18
- Positive: Inventory ratio change, % of -0.15 <= 0
- Positive: Interest expense per share per price, % of 1.19 <= 3.31
Short-term DGX quotes
Relationship graph
Long-term DGX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $9,872.00MM | $9,211.00MM | $9,871.00MM |
| Operating Expenses | $8,444.00MM | $7,949.00MM | $8,525.00MM |
| Operating Income | $1,428.00MM | $1,262.00MM | $1,346.00MM |
| Non-Operating Income | $-193.00MM | $-132.00MM | $-171.00MM |
| Interest Expense | $138.00MM | $152.00MM | $201.00MM |
| Income(Loss) | $1,235.00MM | $1,130.00MM | $1,175.00MM |
| Taxes | $264.00MM | $248.00MM | $273.00MM |
| Other Income(Loss) | $44.00MM | $26.00MM | $19.00MM |
| Profit(Loss)* | $946.00MM | $854.00MM | $871.00MM |
| Stockholders Equity | $5,893.00MM | $6,307.00MM | $6,778.00MM |
| Inventory | $192.00MM | $190.00MM | $188.00MM |
| Assets | $12,837.00MM | $14,022.00MM | $16,153.00MM |
| Operating Cash Flow | $1,718.00MM | $1,272.00MM | $1,334.00MM |
| Capital expenditure | $404.00MM | $408.00MM | $425.00MM |
| Investing Cash Flow | $-543.00MM | $-1,061.00MM | $-2,548.00MM |
| Financing Cash Flow | $-1,732.00MM | $160.00MM | $1,084.00MM |
| Earnings Per Share** | $8.16 | $7.62 | $7.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.